Providence Therapeutics

Providence Therapeutics Holdings Inc is a clinical-stage biotechnology company focused on drug development and platform development. The Providence mRNA Medicines platform is comprised of three integrated platforms: 1) mRNA Medicines Platform, 2) INTENT™ Lipid Nanoparticle Platform (LNP), and 3) Manufacturing Platform. Providence’s mRNA and INTENT™ LNP platform offer an end-to-end solution for designing codon-optimized ultrapure mRNA that can be formulated in application optimized LNP. The Providence proprietary INTENT™ LNP platform, consists of rationally designed lipids that have been tested for suitability for programs in oncology, infectious diseases and gene delivery. Our scalable, efficient platform demonstrates differentiated capabilities in mRNA design, manufacturing, and formulation processes, as well as specific organ and tissue targeting. For more information, please visit providencetherapeutics.com